---
$id: https://graph.org.ai/products/commodity/51152034
$type: Product
source: UNSPSC
code: "51152034"
title: "Lanperisone"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lanperisone

**UNSPSC Code**: 51152034
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TO2JP2G53H. European Medicines Agency schedules Lanperisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08400MIG. Lanperisone generally arises in the molecular formula C15H18F3NO. The term LANPERISONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, no. 3, 1995, list 35.) LANPERISONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lanperisone under HS 29339990 and SITC 51577. As of Q4 2014, LANPERISONE remains the US FDA Preferred Term for this commodity. Lanperisone bears US NLM identifiers UMLS ID C2697881 and NCI Concept Code C79785. SMILES: FC(F)(F)C1CCC(C(=O)C(CN2CCCC2)C)CC1.

